Overview


According to FutureWise analysis the market for effervescent tablet in 2023 is US$ 9.8 billion, and is expected to reach US$ 19.39 billion by 2031 at a CAGR of 8.90%.

Effervescent tablets are carbon dioxide-releasing tablets that dissolve quickly in water or another liquid. The tablet dissolves into a frothy or fizzy solution due to the quick breakdown. These pills can be used to give a wide range of medications. There are several advantages to using these tablets. One of the most notable advantages of the medications is that they promptly transport pharmaceuticals to the body because they are delivered in the form of a readily absorbed solution.

The increased prevalence of chronic diseases around the world will function as a primary driver, causing the market's growth rate to accelerate. When effervescent is introduced to a liquid, bubbles form and the liquid becomes bubbly. They're easy to use, requiring only a drop of water to generate a solution. They offer a considerable advantage when eaten because they are already in the form of a solution when taken, allowing for faster absorption and pain alleviation than standard tablets. These tablets can be used for a variety of ailments and provide rapid relief from headaches, acid reflux, and indigestion. Creatine tabs, pre-workout tabs, BCAA tabs, and other sports supplements comprise effervescent tablets.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Effervescent Tablet Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Effervescent Tablet Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Herbalife International of America, Inc.
  • Bayer AG
  • Perrigo Company plc
  • Reckitt Benckiser Group PLC
  • Bristol-Myers Squibb Company
  • CHIESI SAS
  • Hermes Pharma
  • S. G. Biopharm Pvt. Ltd
  • Bliss GVS Pharma Limited
  • SCITECH
  • Alpex
  • Vovantis Laboratories
  • Herbalife International of America, Inc.
  • Swisse Wellness PTY LTD
  • Nuun
  • Natur Produkt Zdrovit Sp Z O O
  • Vitabiotics Ltd
  • Amerilab Technologies Inc.
  • HERMES ARZNEIMITTEL

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Products

  • Medication
  • Supplements

By Methods

  • Dry Methods
  • Wet Granulation

By Indication

  • Diuretics
  • Pain Management
  • Gastric Disorders
  • Respiratory Diseases
  • Others

By Population Type

  • Children
  • Adults

By Application

  • Dental Products
  • Dietary Supplements
  • Pharmaceutical
  • Others

By Type

  • Prescription
  • Over the Counter

By End-Users

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Effervescent Tablet Market By Products, By Methods, By Indication, By Population Type, By Application, By Type, By End-Users and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Effervescent Tablet Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Effervescent Tablet Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Effervescent Tablet Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Effervescent Tablet Market, By Products Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Medication
        2. Supplements

  • 8.   Effervescent Tablet Market, By Methods Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Dry Methods
        2. Wet Granulation

  • 9.   Effervescent Tablet Market, By Indication Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Diuretics
        2. Pain Management
        3. Gastric Disorders
        4. Respiratory Diseases
        5. Others

  • 10.   Effervescent Tablet Market, By Population Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Children
        2. Adults

  • 11.   Effervescent Tablet Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Dental Products
        2. Dietary Supplements
        3. Pharmaceutical
        4. Others

  • 12.   Effervescent Tablet Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Prescription
        2. Over the Counter

  • 13.   Effervescent Tablet Market, By End-Users Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others

  • 14.   Effervescent Tablet Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
        4. Others

  • 15.   North America Effervescent Tablet Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 16.   Latin America Effervescent Tablet Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 17.   Europe Effervescent Tablet Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 18.   Asia Pacific Effervescent Tablet Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 19.   Middle East and Africa Effervescent Tablet Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 20.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 21.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Pfizer Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. GlaxoSmithKline plc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Herbalife International of America, Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Bayer AG
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Perrigo Company plc
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Reckitt Benckiser Group PLC
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Bristol-Myers Squibb Company
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. CHIESI SAS
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Hermes Pharma
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. S. G. Biopharm Pvt. Ltd
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
         11. Bliss GVS Pharma Limited
          11.1. Company Overview
          11.2. Product Portfolio
          11.3. SWOT Analysis
            11.4. Financial Overview
          11.5. Strategic Overview
         12. SCITECH
          12.1. Company Overview
          12.2. Product Portfolio
          12.3. SWOT Analysis
          12.4. Financial Overview
          12.5. Strategic Overview
         13. Alpex
          13.1. Company Overview
          13.2. Product Portfolio
          13.3. SWOT Analysis
          13.4. Financial Overview
          13.5. Strategic Overview
         14. Vovantis Laboratories
          14.1. Company Overview
          14.2. Product Portfolio
          14.3. SWOT Analysis
          14.4. Financial Overview
          14.5. Strategic Overview
        15. Herbalife International of America, Inc.
          15.1. Company Overview
          15.2. Product Portfolio
          15.3. SWOT Analysis
          15.4. Financial Overview
          15.5. Strategic Overview
         16. Swisse Wellness PTY LTD
          16.1. Company Overview
          16.2. Product Portfolio
          16.3. SWOT Analysis
          16.4. Financial Overview
          16.5. Strategic Overview
         17. Nuun
          17.1. Company Overview
          17.2. Product Portfolio
          17.3. SWOT Analysis
          17.4. Financial Overview
          17.5. Strategic Overview
         18. Natur Produkt Zdrovit Sp Z O O
          18.1. Company Overview
          18.2. Product Portfolio
          18.3. SWOT Analysis
          18.4. Financial Overview
          18.5. Strategic Overview
         19. Vitabiotics Ltd
          19.1. Company Overview
          19.2. Product Portfolio
          19.3. SWOT Analysis
          19.4. Financial Overview
          19.5. Strategic Overview
        20. Amerilab Technologies Inc.
          20.1. Company Overview
          20.2. Product Portfolio
          20.3. SWOT Analysis
          20.4. Financial Overview
          20.5. Strategic Overview
        21. HERMES ARZNEIMITTEL
          21.1. Company Overview
          21.2. Product Portfolio
          21.3 SWOT Analysis
          21.4. Financial Overview
          21.5. Strategic Overview

  • 22.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 23.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients